Switching to second line MS disease-modifying therapies is associated with decreased relapse rate

BACKGROUND AND OBJECTIVES: While randomized, controlled trials (RCTs) are the gold standard for determining treatment efficacy, they do not capture the effectiveness of treatment during real-world use. We aimed to evaluate the association between demographics and multiple sclerosis (MS) disease-modi...

Descripción completa

Detalles Bibliográficos
Autores principales: Marriott, James John, Ekuma, Okechukwu, Fransoo, Randall, Marrie, Ruth Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511745/
https://www.ncbi.nlm.nih.gov/pubmed/37745666
http://dx.doi.org/10.3389/fneur.2023.1243589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511745/
https://www.ncbi.nlm.nih.gov/pubmed/37745666
http://dx.doi.org/10.3389/fneur.2023.1243589

Ejemplares similares